Gilead Sciences, Inc. SEC filings GILD
Gilead Sciences, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Apr 2, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Mar 27, 2025 | — |
| DEF 14A | Proxy statement | Mar 27, 2025 | May 7, 2025 |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEF 14A | Proxy statement | Mar 28, 2024 | May 8, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2024 | May 8, 2024 |
| DEF 14A | Proxy statement | Mar 23, 2023 | — |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEFA14A | Additional proxy material | Mar 24, 2022 | — |
| DEF 14A | Proxy statement | Mar 24, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Mar 30, 2021 | — |
| DEF 14A | Proxy statement | Mar 30, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Apr 15, 2020 | — |
| DEFA14A | Additional proxy material | Mar 24, 2020 | — |
| DEF 14A | Proxy statement | Mar 24, 2020 | May 6, 2020 |
| DEFA14A | Additional proxy material | Mar 25, 2019 | — |
| DEF 14A | Proxy statement | Mar 25, 2019 | May 8, 2019 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2019 | May 8, 2019 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GILD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 882095
- Former names
- GILEAD SCIENCES INC (until Feb 17, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.